Nanobiotix (ADR) (NBTX)
Develops radiotherapy-activated nanoparticle candidates for solid tumors.
$35.44
vs last close+0.94 (+2.73%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 11.45% | 5.79M ADS | |
|---|---|---|---|
| 19 holders · as of Jun 30, 2026 | |||
| Insiders | 15.94% | 8.06M ADS | |
| 2 holders · as of Apr 17, 2025 | |||
| Other | 72.61% | 36.74M ADS | |
| remainder | |||
50.60M ADS as of Sep 12, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
The share count is from the company's Dec 2022 annual report; nothing newer is on file here.
13F, as of Jun 30, 2026
19 holders · 5.79M shares · 7 new positions · 13 increased · 2 reduced · 3 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Johnson & Johnson | 5.62M | 11.11% | 0 | Aug 6, 2026 |
| Morgan Stanley | 49.8K | 0.10% | +13.5K | Aug 13, 2026 |
| Jane Street Group, LLC | 32.2K | 0.06% | +32.2Knew | Aug 14, 2026 |
| HRT Financial LP | 27.3K | 0.05% | +27.3Knew | Aug 14, 2026 |
| XTX Topco Ltd | 15.9K | 0.03% | +15.9Knew | Aug 14, 2026 |
| Optiver Holding B.V. | 13.6K | 0.03% | +130 | Aug 12, 2026 |
| Marshall Wace, LLP | 10.0K | 0.02% | +805 | Aug 13, 2026 |
| Citadel Advisors LLC | 6.0K | 0.01% | +6.0Knew | Sep 2, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Invus Public Equities, L.P. | 8.90% | 4.23M | 13G | Apr 17, 2025 |
Form 4
Latest trades
Nothing filed in the last 12 months.
House and Senate disclosures
Not reported.